Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma

被引：0
|
作者：
V. E. Goldberg
T. Yu. Polyakova
N. O. Popova
V. V. Vysotskaya
E. I. Simolina
Yu. V. Belevich
T. P. Tuzikova
A. V. Goldberg
V. V. Zhdanov
L. A. Miroshnichenko
E. V. Udut
E. V. Simanina
A. M. Dygai
G. N. Zyuz’kov
机构：
[1] E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine,
[2] Research Institute of Oncology,undefined
[3] Tomsk National Research Medical Center,undefined
[4] National Research Tomsk State University,undefined
来源：
Bulletin of Experimental Biology and Medicine | 2017年 / 163卷
关键词：
non-small-cell lung carcinoma; granulocytopoiesis; erythropoiesis; docetaxel; cisplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The toxic effects of combined cisplatin/docetaxel therapy cycles on erythroid and granulocytic hematopoietic lineages as well as their intercycle recovery were examined in patients with stage III-IV non-small-cell lung carcinoma. Responsiveness of the blood system to this therapy remained at a high level. Combined therapy pronouncedly activated the key elements of the erythroid and granulocytic hematopoietic lineages leading to accumulation of immature and mature myelokaryocytes in the bone marrow, enlargement of the medullary pool of mature neutrophils, and increase in the count of medullary erythroid and granulocytic precursor cells under conditions of their accelerated maturation.
引用
收藏
页码：469 / 474
页数：5
相关论文
共 50 条
  • [31] Assessing the Robustness and Reproducibility of CT Radiomics Features in Non-small-cell Lung Carcinoma
    Pasini, Giovanni
    IMAGE ANALYSIS AND PROCESSING - ICIAP 2023 WORKSHOPS, PT II, 2024, 14366 : 39 - 48
  • [32] A case of recurrent non-small-cell lung carcinoma and paraneoplastic Cushing's syndrome
    Noorlander, I
    Elte, JW
    Manintveld, OC
    Tournoy, KG
    Praet, MM
    van Meerbeeck, JP
    Aerts, JG
    LUNG CANCER, 2006, 51 (02) : 251 - 255
  • [33] Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma
    Gastaud, Lauris
    Ambrosetti, Damien
    Otto, Josiane
    Marquette, Charles-Hugo
    Coutts, Michael
    Hofman, Paul
    Esnault, Vincent
    Favre, Guillaume
    LUNG CANCER, 2013, 82 (02) : 362 - 364
  • [34] Genep73: Deletions and expression in non-small-cell lung carcinoma cells
    V. V. Chizhikov
    I. B. Zborovskaya
    A. G. Tatosyan
    A. V. Gasparyan
    Molecular Biology, 2000, 34 : 403 - 407
  • [35] A review on engineered magnetic nanoparticles in Non-Small-Cell lung carcinoma targeted therapy
    Ngema, Lindokuhle M.
    Adeyemi, Samson A.
    Marimuthu, Thashree
    Choonara, Yahya E.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 606
  • [36] Deep learning to estimate response of concurrent chemoradiotherapy in non-small-cell lung carcinoma
    Peng, Jie
    Zhang, Xudong
    Hu, Yong
    He, Tianchu
    Huang, Jun
    Zhao, Mingdan
    Meng, Jimei
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [37] Cytomorphology is Often Insufficient to Categorize Non-Small-Cell Lung Carcinoma on FNA Specimens
    Witt, Benjamin L.
    Cohen, Michael B.
    Chadwick, Barbara E.
    Stephenson, Philip D.
    Abasolo, Peter
    Schmidt, Robert L.
    DIAGNOSTIC CYTOPATHOLOGY, 2016, 44 (02) : 73 - 79
  • [38] Phenotyping the Histopathological Subtypes of Non-Small-Cell Lung Carcinoma: How Beneficial Is Radiomics?
    Pasini, Giovanni
    Stefano, Alessandro
    Russo, Giorgio
    Comelli, Albert
    Marinozzi, Franco
    Bini, Fabiano
    DIAGNOSTICS, 2023, 13 (06)
  • [39] The role of molecular pathology in non-small-cell lung carcinoma-now and in the future
    Brandao, G. D. A.
    Brega, E. F.
    Spatz, A.
    CURRENT ONCOLOGY, 2012, 19 : S24 - S32
  • [40] Bilateral Ulcerative Keratitis Associated With Afatinib Treatment for Non-Small-cell Lung Carcinoma
    McKelvie, James
    McLintock, Cameron
    Elalfy, Mohamed
    CORNEA, 2019, 38 (03) : 384 - 385
12345